A Study of Aripiprazole in the Management of Patients With Schizophrenia in the General Psychiatric Practices
Clinical trial NCT00237939 · COMPLETED
Trial details
- NCT number
- NCT00237939
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-09-01
- Primary completion
- 2006-11-01
- Enrollment
- 1200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.